Sandu Pharmaceuticals Limited (SANDUPHQ.BO)
INR 56.0
(-0.37%)
INR 56.0
(-0.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 672.8 Million INR | 2.96% |
| 2022 | 653.49 Million INR | -0.23% |
| 2021 | 655 Million INR | 11.5% |
| 2020 | 587.44 Million INR | 21.45% |
| 2019 | 483.67 Million INR | -2.14% |
| 2018 | 494.24 Million INR | 0.83% |
| 2017 | 490.15 Million INR | 14.46% |
| 2016 | 428.25 Million INR | 4.25% |
| 2015 | 410.78 Million INR | 3.73% |
| 2014 | 396.01 Million INR | 10.12% |
| 2013 | 359.6 Million INR | 19.12% |
| 2012 | 301.89 Million INR | -3.38% |
| 2011 | 312.44 Million INR | 44.74% |
| 2010 | 215.86 Million INR | 38.65% |
| 2009 | 155.69 Million INR | 9.19% |
| 2008 | 142.58 Million INR | 5.85% |
| 2007 | 134.69 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 170.45 Million INR | 9.28% |
| 2023 FY | 672.8 Million INR | 2.96% |
| 2023 Q1 | 176.57 Million INR | 15.67% |
| 2023 Q2 | 166.07 Million INR | -5.95% |
| 2023 Q3 | 174.28 Million INR | 4.95% |
| 2023 Q4 | 155.97 Million INR | -10.51% |
| 2022 Q3 | 170.92 Million INR | 1.96% |
| 2022 FY | 653.49 Million INR | -0.23% |
| 2022 Q1 | 162.28 Million INR | 42.06% |
| 2022 Q2 | 167.63 Million INR | 3.3% |
| 2022 Q4 | 152.64 Million INR | -10.69% |
| 2021 Q2 | 175.9 Million INR | 1.47% |
| 2021 Q4 | 114.24 Million INR | -40.34% |
| 2021 FY | 655 Million INR | 11.5% |
| 2021 Q3 | 191.5 Million INR | 8.87% |
| 2021 Q1 | 173.35 Million INR | 22.99% |
| 2020 Q2 | 172.21 Million INR | 47.57% |
| 2020 FY | 587.44 Million INR | 21.45% |
| 2020 Q4 | 140.95 Million INR | -10.61% |
| 2020 Q1 | 116.69 Million INR | 5.93% |
| 2020 Q3 | 157.68 Million INR | -8.44% |
| 2019 Q3 | 131.8 Million INR | 11.46% |
| 2019 Q1 | 123.45 Million INR | 3.56% |
| 2019 Q4 | 110.16 Million INR | -16.42% |
| 2019 Q2 | 118.25 Million INR | -4.21% |
| 2019 FY | 483.67 Million INR | -2.14% |
| 2018 Q3 | 141.85 Million INR | 16.17% |
| 2018 FY | 494.24 Million INR | 0.83% |
| 2018 Q4 | 119.2 Million INR | -15.97% |
| 2018 Q2 | 122.1 Million INR | 9.92% |
| 2018 Q1 | 111.08 Million INR | -9.15% |
| 2017 FY | 490.15 Million INR | 14.46% |
| 2017 Q2 | 174.91 Million INR | 158.18% |
| 2017 Q3 | 111.64 Million INR | -36.17% |
| 2017 Q4 | 122.27 Million INR | 9.52% |
| 2017 Q1 | 67.74 Million INR | -36.23% |
| 2016 Q1 | 101.34 Million INR | -9.76% |
| 2016 FY | 428.25 Million INR | 4.25% |
| 2016 Q4 | 106.23 Million INR | -4.77% |
| 2016 Q2 | 121.83 Million INR | 20.22% |
| 2016 Q3 | 111.55 Million INR | -8.43% |
| 2015 Q1 | 88.35 Million INR | -22.55% |
| 2015 Q3 | 105.49 Million INR | 0.83% |
| 2015 Q4 | 112.29 Million INR | 6.45% |
| 2015 FY | 410.78 Million INR | 3.73% |
| 2015 Q2 | 104.63 Million INR | 18.42% |
| 2014 FY | 396.01 Million INR | 10.12% |
| 2014 Q4 | 114.07 Million INR | 12.22% |
| 2014 Q3 | 101.65 Million INR | 4.17% |
| 2014 Q2 | 97.58 Million INR | 17.99% |
| 2014 Q1 | 82.7 Million INR | -16.42% |
| 2013 Q3 | 91.69 Million INR | -1.98% |
| 2013 FY | 359.6 Million INR | 19.12% |
| 2013 Q4 | 98.95 Million INR | 7.92% |
| 2013 Q1 | 75.41 Million INR | -19.51% |
| 2013 Q2 | 93.54 Million INR | 24.05% |
| 2012 Q3 | 78.5 Million INR | 8.78% |
| 2012 Q1 | 66.23 Million INR | -26.39% |
| 2012 Q2 | 72.16 Million INR | 8.96% |
| 2012 Q4 | 93.69 Million INR | 19.35% |
| 2012 FY | 301.89 Million INR | -3.38% |
| 2011 FY | 312.44 Million INR | 44.74% |
| 2011 Q4 | 89.98 Million INR | 13.88% |
| 2011 Q3 | 79.01 Million INR | 0.0% |
| 2010 Q4 | 50.54 Million INR | 0.0% |
| 2010 FY | 215.86 Million INR | 38.65% |
| 2009 FY | 155.69 Million INR | 9.19% |
| 2009 Q4 | 47.44 Million INR | 0.0% |
| 2008 FY | 142.58 Million INR | 5.85% |
| 2008 Q4 | 47.29 Million INR | 0.0% |
| 2007 Q4 | 31.97 Million INR | 0.0% |
| 2007 FY | 134.69 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -6314.078% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 35.848% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -68.106% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -81.749% |
| Sunil Healthcare Limited | 901.91 Million INR | 25.403% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -3560.14% |
| MedPlus Health Services Limited | 56.24 Billion INR | 98.804% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -50.823% |
| Patidar Buildcon Limited | 2.3 Million INR | -29051.083% |
| Roopa Industries Limited | 715.53 Million INR | 5.972% |
| Smruthi Organics Limited | 1.27 Billion INR | 47.29% |
| Trident Lifeline Limited | 446.28 Million INR | -50.757% |
| PANJON LTD. | 125.52 Million INR | -436.012% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -345.211% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -40.242% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 89.601% |
| Crestchem Limited | 212.56 Million INR | -216.523% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -12018.282% |
| Tyche Industries Limited | 696.83 Million INR | 3.448% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 80.675% |
| Trimurthi Limited | 42.23 Million INR | -1492.895% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 9.779% |
| Norris Medicines Limited | 56.35 Million INR | -1093.849% |
| Zenlabs Ethica Limited | 585.63 Million INR | -14.886% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 46.352% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 53.952% |
| Parmax Pharma Limited | 154.24 Million INR | -336.198% |
| Veerhealth Care Limited | 142.13 Million INR | -373.361% |
| Deccan Health Care Limited | 597.28 Million INR | -12.643% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 85.486% |
| Makers Laboratories Limited | 1.03 Billion INR | 35.159% |
| Lactose (India) Limited | 1.13 Billion INR | 40.925% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -69.72% |
| Zenith Healthcare Limited | 144.71 Million INR | -364.912% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -25.32% |
| Bacil Pharma Limited | - INR | -Infinity% |
| PRAVEG LIMITED | 915.96 Million INR | 26.547% |
| Denis Chem Lab Limited | 1.67 Billion INR | 59.909% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 78.097% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 52.608% |
| Colinz Laboratories Limited | 70.29 Million INR | -857.106% |
| Godavari Drugs Limited | 1.56 Billion INR | 57.067% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -60079.517% |
| Zenotech Laboratories Limited | 368.08 Million INR | -82.784% |
| Panchsheel Organics Limited | 1.05 Billion INR | 36.056% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 46.558% |
| Vivanza Biosciences Limited | 278.89 Million INR | -141.243% |
| Phaarmasia Limited | 305.93 Million INR | -119.92% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 95.039% |
| Medi-Caps Limited | 265.63 Million INR | -153.283% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -85.472% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 60.382% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 61.406% |
| Mercury Laboratories Limited | 755.59 Million INR | 10.956% |
| Gennex Laboratories Limited | 867.14 Million INR | 22.411% |
| BDH Industries Limited | 858.31 Million INR | 21.613% |
| Coral Laboratories Limited | 836.6 Million INR | 19.579% |
| Concord Drugs Limited | 449.24 Million INR | -49.764% |
| Bharat Parenterals Limited | 2.59 Billion INR | 74.064% |
| Beryl Drugs Limited | 271.24 Million INR | -148.042% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -553.985% |
| Evoq Remedies Limited | 63.09 Million INR | -966.424% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 66.707% |
| Transchem Limited | 4.09 Million INR | -16309.931% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -342.998% |
| Parnax Lab Limited | 1.88 Billion INR | 64.347% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -146.478% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 34.255% |
| Cian Healthcare Limited | 616.95 Million INR | -9.053% |
| Trinity League India Limited | 2.95 Million INR | -22707.017% |
| Syschem (India) Limited | 2.33 Billion INR | 71.19% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 56.71% |
| Auro Laboratories Limited | 526.99 Million INR | -27.668% |